Synthesized oligonucleotides are used for various applications in the life science and medical industry for research purposes as a probe for DNA synthesis and sequencing, probes for the detection of complementary RNA and DNA through hybridization in clinical developments and synthesis of artificial genes.
Global oligonucleotides synthesis market is projected to register a substantial CAGR of 9.3% in the forecast period of 2019 to 2026.
Some of the major players operating in this market are Agilent Technologies, Inc., Atdbio Ltd., LGC Limited, Bio-Synthesis Inc., Eurofins Genomics, Kaneka Eurogentec S.A., General Electric, Genscript, AJINOMOTO CO.,INC (Genedesign, Inc.), Danaher, Merck Kgaa, Lgc Biosearch Technologies, Nitto Denko, Thermo Fisher Scientific, Trilink Biotechnologies, Llc, Biolytic Lab Performance Inc., Polygen Gmbh, Quintara Biosciences, Bio Basic Inc., Danaher (Integrated Dna Technologies, Inc.), and Twist Bioscience among others.
Get Sample Analysis of Global Market Information: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-oligonucleotide-synthesis-market
The oligo nucleotides services provided by the manufacturers are available based on the customer requirement which helps in the identification of specific genes in life science research procedures. Various types of fragment oligo nucleotides are available which are prepared and used by different sectors such as for research of life science, the oligos are used as PCR primers and probes, DNA sequencing, gene editing (CRISPR), for the diagnostics applications, the oligos are used as microarrays/gene panels, fluorescence in situ hybridization and for therapeutic applications, the oligo nucleotides are used as nucleic acid aptamers, antisense, gene and cell therapy and others.
The wide range of applications in the field of research, diagnostics, therapeutics, drug discovery, data storage and synthetic biology and growing research oriented programs are boosting the requirement of the oligonucleotide in medical sector.
The overall market of synthesized oligonucleotides is growing tremendously due to high growth in the life science industries and growing applications in therapeutics and in genetics and genomics in the research and diagnostics.
Segmentation: Global Oligonucleotides Synthesis Market
Global oligonucleotides synthesis market is segmented into six notable segments which are product type, type, consumables, service type, application and end user.
- On the basis of product type, the market is segmented into DNA Oligonucleotides and RNA Oligonucleotides.
- In March 2015, TriLink BioTechnologies, LLC introduced their new technology Clean Tag which is designed to provide efficiency in the NGS library preparation. The technology is designed for the clinical research purpose that helps in eliminating the gel purification process and advances the work flow method. The introduction of the new technology helping the researchers in NGS library and enhancing the advanced product offering of the company.
- On the basis of type, the market is segmented into oligonucleotide-based drugs, primers, probes, intermediate-scale synthesized oligos, large-scale synthesized oligos, linkers & adaptors and array-based oligos.
- In September 2018, Maravai LifeSciences (U.S.) announced the lease of new facility to expand the business of lifescience sector for TriLink BioTechnologies, LLC in San Diego, U.S. The new facility will help the company to make the business position globally and helps for the continuous growth in the life science market.
- On the basis of consumables, the market is segmented into instruments, kits & reagents and others.
- In May 2019, QIAGEN announced launch of PIK3CA RGQ PCR kit to improve the health of patient with breast cancer. This uses plasma specimens during liquid biopsy. With this there will be improved diagnostics for genetic abnormalities and hence increased product portfolio of a company.
- On the basis of service type, the market is segmented into custom oligos, predesigned oligos and oligo synthesis.
- In September 2018, Kaneka Eurogentec S.A. had introduced Therapeutic Oligonucleotides for early clinical phases. GMP is certified by Belgium Authorities. With this there is an increased production of clinical and pre-clinical Oligonucleotides.
- On the basis of application, the market is segmented into research applications, therapeutic applications, diagnostic applications and others.
- In April 2019, GenScript launched single-stranded DNA service for the CRISPR based gene editing. This would help the researchers to accelerate the advancement of cell therapy, gene therapy as well as the transgenic animal models for the cancer research and treatments.
- On the basis of end user, the market is segmented into biopharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, hospitals and others.
- In December 2018, Biolytic Lab Performance Inc. introduced the Dr. Oligo 192c which is designed for the synthesis of bio molecules. The redesign of the Dr. Oligo 48 enhances the process output and helping the researchers in the cost reduction in synthesis process. The new introduction of the instrument will expand the business of the company globally and helps in offering the product overseas.
Get TOC of Full Report: https://www.databridgemarketresearch.com/toc/?dbmr=global-oligonucleotide-synthesis-market
Product Launch
- In April 2019, GenScript launched single-stranded DNA service for the CRISPR based gene editing. This would help the researchers to accelerate the advancement of cell therapy, gene therapy as well as the transgenic animal models for the cancer research and treatments.
- In September 2018, Kaneka Eurogentec S.A. had introduced Therapeutic Oligonucleotides for early clinical phases. GMP is certified by Belgium Authorities. With this there is an increased production of clinical and pre-clinical Oligonucleotides.
North America oligonucleotides synthesis market is projected to register a substantial CAGR in the forecast period of 2019 to 2026.Synthesized oligonucleotides are used for various applications in the life science and medical industry for research purposes as a probe for DNA synthesis and sequencing, probes for the detection of complementary RNA and DNA through hybridization in clinical developments and synthesis of artificial genes.The oligo nucleotides services provided by the manufacturers are available based on the customer requirement which helps in the identification of specific genes in life science research procedures.
Various types of fragment oligo nucleotides are available which are prepared and used by different sectors such as for research of life science, the oligos are used as PCR primers and probes, DNA sequencing, gene editing (CRISPR), for the diagnostics applications, the oligos are used as microarrays/gene panels, fluorescence in situ hybridization and for therapeutic applications, the oligo nucleotides are used as nucleic acid aptamers, antisense, gene and cell therapy and others.The wide range of applications in the field of research, diagnostics, therapeutics, drug discovery, data storage and synthetic biology and growing research oriented programs are boosting the requirement of the oligonucleotide in medical sector.The overall market of synthesized oligonucleotides is growing tremendously due to high growth in the life science industries and growing applications in therapeutics and in genetics and genomics in the research and diagnostics.Download Exclusive Sample Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-oligonucleotides-synthesis-marketCompetitive Analysis: North America Oligonucleotides Synthesis Market Some of the major players operating in this market are Agilent Technologies, Inc., Atdbio Ltd., LGC Limited, Bio-Synthesis Inc., Eurofins Genomics, Kaneka Eurogentec S.A., General Electric, Genscript, AJINOMOTO CO.,INC (Genedesign, Inc.), Danaher, Merck Kgaa, Lgc Biosearch Technologies, Nitto Denko, Thermo Fisher Scientific, Trilink Biotechnologies, Llc, Biolytic Lab Performance Inc., Polygen Gmbh, Quintara Biosciences, Bio Basic Inc., Danaher (Integrated Dna Technologies, Inc.), and Twist Bioscience among others.Product LaunchesIn July 2019, Twist Bioscience Corporation launched long oligonucleotides product line which is designed up to 300 nucleotides and is longest commercial oligo which helps in continuous chemical synthesis.
The launch of new product helps in enhancing the product offering of company and enhancing the biological research activity with the help of longest synthetic oligos.In May 2019, QIAGEN announced launch of PIK3CA RGQ PCR kit to improve the health of patient with breast cancer.
This uses plasma specimens during liquid biopsy.
With this there will be improved diagnostics for genetic abnormalities and hence increased product portfolio of a company.To Insightful Report Details Visit https://www.databridgemarketresearch.com/reports/north-america-oligonucleotides-synthesis-marketSegmentation: North America Oligonucleotides Synthesis Market North America oligonucleotides synthesis market is segmented into six notable segments which are product type, type, consumables, service type, application and end user.· On the basis of product type, the market is segmented into DNA Oligonucleotides and RNA Oligonucleotides.· On the basis of type, the market is segmented into oligonucleotide-based drugs, primers, probes, intermediate-scale synthesized oligos, large-scale synthesized oligos, linkers & adaptors and array-based oligos.· On the basis of technique, the market is segmented into polymerase chain reaction, ELISA, DNA staining/ indirect assay, enzymatic methods, microbial culture techniques /direct assay and others· On the basis of consumables, the market is segmented into instruments, kits & reagents and others.· On the basis of disease area, the market is segmented into urogenital, respiratory, cardiovascular, musculoskeletal, gastrointestinal and others· On the basis of service type, the market is segmented into custom oligos, predesigned oligos and oligo synthesis.· On the basis of end user, the market is segmented into hospitals, diagnostic laboratories and others· On the basis of application, the market is segmented into research applications, therapeutic applications, diagnostic applications and others.· On the basis of end user, the market is segmented into bio-pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, hospitals and others.Access Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/north-america-oligonucleotides-synthesis-marketResearch Methodology: North America Oligonucleotides Synthesis Market Primary Respondents:Key Opinion Leaders (KOL’s): Manufacturers, Researchers, Distributors, Bakers and Food Industrialists.Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and National Sales Managers.Request for Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=north-america-oligonucleotides-synthesis-marketBrowse Trending Related Reports @· Cardiac Rhythm Management Market· Exosome Research Products Market· Image-Guided Radiation Therapy Market· Metagenomics Market· Sutures MarketAbout Data Bridge Market Research:Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.
We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the marketContact:Data Bridge Market ResearchTel: +1-888-387-2818Email: [email protected]
Oligonucleotides Synthesis Market report provides complete background analysis of the Healthcare IT industry which includes an assessment of the parental market.
By thinking from customer point of view, a team of researchers, analysts and industry experts work carefully to generate this Oligonucleotides Synthesis Market research report.
A high quality global market research is brought together for the success of your business at international level.
Competitor analysis is one of the most important aspects of market research report which helps businesses decide upon the strategies by comparing them with the competitors.
Besides, this Oligonucleotides Synthesis Market research report makes clients aware about the various strategies that are used by key players of the market.Global oligonucleotides synthesis market is projected to register a substantial CAGR of 9.3% in the forecast period of 2019 to 2026.Request Sample Report at @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-oligonucleotide-synthesis-marketTop Manufacturers Covered in the Report:Some of the major players operating in this market are Agilent Technologies, Inc., Atdbio Ltd., LGC Limited, Bio-Synthesis Inc., Eurofins Genomics, Kaneka Eurogentec S.A., General Electric, Genscript, AJINOMOTO CO.,INC (Genedesign, Inc.), Danaher, Merck Kgaa, Lgc Biosearch Technologies, Nitto Denko, Thermo Fisher Scientific, Trilink Biotechnologies, Llc, Biolytic Lab Performance Inc., Polygen Gmbh, Quintara Biosciences, Bio Basic Inc., Danaher (Integrated Dna Technologies, Inc.), and Twist Bioscience among others.Product LaunchIn April 2019, GenScript launched single-stranded DNA service for the CRISPR based gene editing.
This would help the researchers to accelerate the advancement of cell therapy, gene therapy as well as the transgenic animal models for the cancer research and treatments.In September 2018, Kaneka Eurogentec S.A. had introduced Therapeutic Oligonucleotides for early clinical phases.
Synthetic biology has an array of applications in the fields of medicine, agriculture, nanotechnology, and industrial biotechnology.
This has attracted interests of researchers from across the globe and has led to a rise in funding from public and private organizations, which, in turn, help in the growth of the market.Get Sample Copy of This Report@https://www.marketsandmarkets.com/requestsampleNew.asp?id=889Some of The Major Players In Synthetic Biology Market:1.
DNA Technologies (US)Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889* Synthetic biology can broadly be described as the engineering and design of new biological parts and functions such as artificial biological pathways and organisms, which can further be used to produce end-products such as biofuels, biosensors, etc.
Synthetic biology also includes the redesign of natural biological systems.
* The global synthetic biology market is segmented on the basis of tool, technology, application, and region.
Based on tools, the market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids.
Monoclonal Antibody Therapy Market OverviewMonoclonal antibodies are laboratory-produced antibodies that are whose purpose is to serve as the substitute of natural antibodies that can enhance or repeat the immune system's attack on harmful cells.
Market Research Future (MRFR) has published and released a research report about the global monoclonal antibody therapy market that estimates boost for this market at 10.5% CAGR (Compound Average Growth Rate) between 2016 and 2022.
In terms of market value, the worth of global monoclonal antibody therapy market has been estimated to be the US $ 140 bn by the end of the forecast period.Analyzing the market structure, this report offers insights about factors affecting the market growth.
Estimating the market size and forecasting the revenue, this reports covers and observes the competitive developments of market players that include mergers and acquisitions, joint ventures, new product developments, research and developments (R), and strategic alliances.The major factors strengthening the growth of the global monoclonal antibody therapy market are rising health awareness, an unhealthy lifestyle lowering the immunity of consumers and increasing spending on healthcare.The global monoclonal antibody therapy market has been segmented on the basis of application, end user, source, and lastly, region.
The application-based segmentation segments this market into analytical & chemical uses, autoimmune diseases, cancer treatment, diagnostic test, hematological disorders, and others.
Regarding source, the market has been segmented into chimeric, human, humanized, recombinant, and other.The regional segmentation of the global blood glucose test strip market segments the global market into regional markets known as The Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa.
Recent findings on the growth of global facial rejuvenation market demonstrate that the demand for such treatments is not restricted to women.
The fear of undergoing multiple cosmetic surgeries and deforming the existing facial appearance continues to divert more consumers for facial rejuvenation, which is essentially a combination cosmetic surgery.
The effectiveness of results is also slated to ramp up the growth of global facial rejuvenation market.
According to its forecast report, titled “Global Market Study on Facial Rejuvenation: Early Onset of Ageing & Rising Adoption of minimally Invasive Procedures to Drive the Market,” the global facial rejuvenation market will expand at a steady CAGR of 4.9% and reach US$ 26.5 billion market value by the end of 2021.
Some of the treatments for facial rejuvenation are invasive yet the patient endures less pain, which incidentally results into positive feedback.
While lack of documented evidence continues to inhibit the growth of global facial rejuvenation market by instilling skepticism in consumers, the real threat for the market has been ensued by irregular international regulations for cosmetic surgeries, unavailability of professionals and growing presence of counterfeit cosmetic surgery products and equipment.
The global egg yolk lecithin market is anticipated grow at a CAGR of 6.0% over the forecast period 2019-2029.
In this egg yolk lecithin market forecast report, the following years are considered to predict the market footprint:History Year: 2014-2018Estimated Year: 2014Forecast Year: 2019-2029The business intelligence study of the egg yolk lecithin market covers the estimation size of the market both in terms of value and volume.
In a bid to recognize the growth prospects in the egg yolk lecithin market, the market study has been geographically fragmented into important regions that are progressing faster than the overall market.A meaningful evolution of the processed food industry in recent years has brought about an increase in the consumption of functional foods, one such ingredient being egg yolk lecithin.
The boost garnered by the rise of global disposable income on the backdrop of increased employment rates has lead people to spend on nutritional products such as egg yolk lecithin supplements.To maintain heart health and body weight, consumers have shifted their focus towards activities such as dieting and exercising.
Some of the diets require consumption of supplements, which provide essential micronutrients to give a boost to performance.
One such supplement is egg yolk lecithin.
